21 May 2013
Keywords: euro, patent, pozen, migraine, drug, usa, been
Article | 31 January 2005
Pozen of the USA has been issued a European Patent, No 0957914 (Formulation of 5-HT Agonists), covering its MT 400 technology. MT 400 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.